Access to Market & Regulatory

We provide Regulatory services throughout Asia

Access-to-market You want to work with a team that has deep experience in registering pharmaceutical/Biotech products and in maintaining updated product licenses.

We always look for “fast track” ways to register your products. Patient access to treatment is our main objective. Orphan drug registration is also important to consider.

All regulatory requirements for Named patient sales (NPS) or clinical trials importation are taken care of and managed by AxxessBio.

AxxessBio also coordinates post marketing surveillance, secures pharmaco vigilance operations and regulatory reporting functions.

For more information about our Regulatory & Market access service